Palma P N, Rodrigues M L, Archer M, Bonifácio M J, Loureiro A I, Learmonth D A, Carrondo M A, Soares-da-Silva P
Department of Research and Development, Bial., A. Av. da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Trofa, Portugal.
Mol Pharmacol. 2006 Jul;70(1):143-53. doi: 10.1124/mol.106.023119. Epub 2006 Apr 17.
In this work, we present a comparative case study of "ortho-" and "meta-nitrated" catecholic inhibitors of catechol-O-methyltransferase (COMT), with regard to their interaction with the catalytic site of the enzyme and the in vitro regioselective formation of their mono-O-methyl ether metabolites. In particular, the effects of altering the attachment position of the inhibitors' side-chain substituent, within the classic nitrocatechol pharmacophore, were investigated. For this purpose, we compared two simple regioisomeric nitrocatechol-type inhibitors of COMT, BIA 3-228 and BIA 8-176, which contain the benzoyl substituent attached at the meta and ortho positions, respectively, relative to the nitro group. The two compounds were slowly O-methylated by COMT in vitro, but the particular substitution pattern of each compound was shown to have a profound impact on the regioselectivity of their O-methylation. To provide a plausible interpretation of these results, a comprehensive analysis of the protein-inhibitor interactions and of the relative chemical susceptibility to O-methylation of the catechol hydroxyl groups was performed by means of docking simulations and ab initio molecular orbital calculations. The major structural and chemical factors that determine the enzyme regioselectivity of O-methylation were identified, and the X-ray structure of the complex of COMT with S-adenosyl-l-methionine and BIA 8-176 is herein disclosed. This is the first reported structure of the soluble form of COMT complexed with a nitrocatecholic inhibitor having a bulky substituent group in adjacent position (ortho) to the nitro group. Structural and dynamic aspects of this complex are analyzed and discussed, in the context of the present study.
在本研究中,我们针对儿茶酚-O-甲基转移酶(COMT)的“邻位”和“间位硝化”儿茶酚类抑制剂,就其与该酶催化位点的相互作用以及它们单-O-甲基醚代谢物的体外区域选择性形成进行了比较案例研究。特别地,研究了在经典硝基儿茶酚药效团内改变抑制剂侧链取代基连接位置的影响。为此,我们比较了两种简单的COMT区域异构体硝基儿茶酚型抑制剂BIA 3-228和BIA 8-176,它们分别含有相对于硝基连接在间位和邻位的苯甲酰基取代基。这两种化合物在体外被COMT缓慢O-甲基化,但每种化合物的特定取代模式对其O-甲基化的区域选择性有深远影响。为了对这些结果给出合理的解释,通过对接模拟和从头算分子轨道计算,对蛋白质-抑制剂相互作用以及儿茶酚羟基对O-甲基化的相对化学敏感性进行了全面分析。确定了决定酶O-甲基化区域选择性的主要结构和化学因素,并在此公开了COMT与S-腺苷-L-甲硫氨酸和BIA 8-176复合物的X射线结构。这是首次报道的COMT可溶性形式与硝基儿茶酚抑制剂形成的复合物的结构,该抑制剂在与硝基相邻位置(邻位)具有庞大取代基。在本研究的背景下,对该复合物的结构和动力学方面进行了分析和讨论。